• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Harmony Biosciences Holdings Inc (NQ: HRMY )

    33.08 +0.95 (+2.96%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Harmony Biosciences Holdings Inc

    < Previous 1 2 3 4 5 6 7 Next >
    2 Magnificent Growth Stocks to Buy Right Now
    These two biotech stocks could be big winners for patient investors. 
    Via The Motley Fool
    Expert Ratings for Harmony Biosciences
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
    Via Benzinga
    9 Analysts Have This to Say About Harmony Biosciences
    Via Benzinga
    Expert Ratings for Harmony Biosciences
    Via Benzinga
    The Latest Analyst Ratings for Harmony Biosciences
    Via Benzinga
    Harmony Biosciences's Earnings Outlook
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
    Via Benzinga
    ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Analyst Expectations for Harmony Biosciences's Future
    Via Benzinga
    Harmony Biosciences Earnings Perspective: Return On Capital Employed
    Via Benzinga
    NASDAQ: HRMY Investor Alert: Investigation over Potential Wrongdoing at Harmony Biosciences Holdings, Inc.
    San Diego, CA -- (SBWIRE) -- 08/17/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Harmony Biosciences Holdings, Inc. 
    Via SBWire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Analyst Expectations for Harmony Biosciences's Future
    Via Benzinga
    Earnings Outlook For Harmony Biosciences
    Via Benzinga
    Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?
    With Harmony Biosciences acquiring Zynerba Pharmaceuticals, ZYNE stock jumped on both the buyout and the underlying therapeutic implications. 
    Via InvestorPlace
    Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals
    Via Benzinga
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today?
    Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares are skyrocketing Monday after Harmony Biosciences (NASDAQ: HRMY) announced it will 
    Via Benzinga
    7 ‘Strong Buy’ Value Stocks You Should Be Loading Up On Now
    Although ultra-cheap ideas tend to carry significant risks, these strong buy value stocks offer the endorsement of analysts. 
    Via InvestorPlace
    Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript
    HRMY earnings call for the period ending June 30, 2023. 
    Via The Motley Fool
    Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
    From Harmony Biosciences
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    7 Best High-Growth Stocks to Buy if You’re a Young Investor
    If you’re just starting out and have plenty of time to work with, these are the high-growth stocks for young investors. 
    Via InvestorPlace
    3 Biotech Stocks to Buy With Explosive Upside Potential
    These three biotech stocks with high upside potential also display some significant risk, but less so than many of their small-cap peers. 
    Via InvestorPlace
    Bragar Eagel & Squire, P.C. Is Investigating Techtronic, Boxed, Coinbase, and Harmony and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript
    HRMY earnings call for the period ending March 31, 2023. 
    Via The Motley Fool
    Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
    From Harmony Biosciences
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating LivePerson, and Harmony and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.